TY - JOUR T1 - Cost-effectiveness of internet-delivered cognitive behaviour therapy for body dysmorphic disorder: results from a randomised controlled trial JF - medRxiv DO - 10.1101/2021.08.23.21262455 SP - 2021.08.23.21262455 AU - Oskar Flygare AU - Erik Andersson AU - Gjermund Glimsdal AU - David Mataix-Cols AU - Diana Djurfeldt AU - Christian Rück AU - Jesper Enander Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/25/2021.08.23.21262455.abstract N2 - Objectives To evaluate the cost-effectiveness of internet-delivered cognitive behaviour therapy for body dysmorphic disorder (BDD-NET).Design Secondary cost-effectiveness analysis from a randomised controlled trial on BDD-NET versus online supportive psychotherapy.Setting Academic medical centre.Participants Self-referred adult patients with a primary diagnosis of body dysmorphic disorder and a score of 20 or higher on the modified Yale-Brown obsessive compulsive scale (n = 94). Patients receiving concurrent psychotropic drug treatment were included if the dose had been stable for at least two months and remained unchanged during the trial.Interventions Participants received either BDD-NET (n = 47) or online supportive psychotherapy (n = 47) for 12 weeks.Primary and secondary outcome measures The primary outcome measures were cost-effectiveness and cost-utility from a societal perspective, using remission status from a diagnostic interview and quality-adjusted life years from EQ-5D, respectively. Secondary outcome measures were cost-effectiveness and cost-utility from a health care perspective and the clinic’s perspective.Results Compared to supportive psychotherapy, BDD-NET produced one additional remission for an average societal cost of $4132. The cost-utility analysis showed that BDD-NET generated one additional QALY to an average cost of $14319 from a societal perspective.Conclusions BDD-NET is a cost-effective treatment for body dysmorphic disorder, compared to online supportive psychotherapy. The efficacy and cost-effectiveness of BDD-NET should be directly compared to face-to-face cognitive behaviour therapy.Trial registration NCT02010619Strengths and limitations of this studyThis is the first cost-effectiveness evaluation of a novel internet-delivered treatment designed to increase access to cognitive behaviour therapy for patients with body dysmorphic disorderCost estimations were self-rated and might not capture all costs associated with treatmentThe self-referred participants were likely motivated to undergo treatment.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02010619Funding StatementThis research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. The original clinical trial was funded through the regional agreement on medical training and clinical research (ALF) between the Region Stockholm and Karolinska Institutet, the Swedish Research Council (no. K2013-61X-22168-01-3) and the Swedish Society of Medicine (Soderstromska Konigska sjukhemmet, no. SLS3B4451). The funders had no part in the study design, in the collection, analysis and interpretation of data, in the writing of the report or in the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the regional ethical review board in Stockholm (2013/1773-31/4) and pre-registered at clinicaltrials.gov (NCT02010619).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets analysed are not publicly available since they contain sensitive personal identifying information and data sharing was not part of the written informed consent, but are available from the corresponding author on reasonable request. Statistical code is publicly available from the Open Science Framework repository: https://doi.org/10.17605/OSF.IO/DC69E https://doi.org/10.17605/OSF.IO/DC69E ER -